Clinical Trials in San Francisco, CA

Browse 243 Clinical Trials San Francisco Across 923 Cities
84 Phase 3 Trial · 8641 Clinical Trials San Francisco Clinics

Display Results

All

Most EffectiveMost SafeSenior FriendlyPediatricNo Placebo

Clinical Trials Clinical Trials in San Francisco, CA

Reviewed by Michael Gill, B. Sc.

Image of University of California, San Francisco in San Francisco, United States.

Phase-Based Progress Estimates

Digital Cognitive Behavior Therapy For Insomnia (CBT-I)for Insomnia

The goal of this clinical trial is to compare two sleep programs in pregnant people with insomnia. The main questions it aims to answer are: What is the efficacy of digital cognitive behavioral therapy for insomnia (CBT-I) versus digital sleep hygiene education (SHE) for preventing perinatal depression? Is the effect of digital CBT-I on perinatal depression mediated through prenatal insomnia symptom improvement? Is the effect of digital CBT-I on perinatal depression moderated by baseline depressive symptom severity? Participants will receive one of two sleep programs - SHE or CBT-I. Both involve six weekly online sessions. Participants will complete surveys and interviews until 1 year postpartum.

University of California, San FranciscoJennifer N Felder, PhD

Image of Research Site in Birmingham, United States.

Phase-Based Progress Estimates

Part A: Treatment Group 1for Liver Cirrhosis

This is a two part Phase IIa/b multicentre, randomised, double-blind, placebo-controlled, parallel group dose-ranging study to assess the efficacy, safety, and tolerability of the combination of zibotentan and dapagliflozin, and dapagliflozin monotherapy versus placebo in participants with cirrhosis with features of portal hypertension.

Research Site (+7 Sites)AstraZeneca

Image of University of Alabama at Birmingham in Birmingham, United States.

Phase-Based Progress Estimates

Arm A - Patients Lacking PIK3CA Mutations (WT)for Breast Cancer

This is a Phase 3, open-label, randomized, clinical trial evaluating the efficacy and safety of gedatolisib plus fulvestrant with or without palbociclib for the treatment of patients with locally advanced or metastatic HR+/HER2- breast cancer following progression on or after CDK4/6 and aromatase inhibitor therapy.

University of Alabama at Birmingham (+69 Sites)Nadene ZackCelcuity, Inc.

Image of Premium Medical Research Corp in Miami, United States.

Phase-Based Progress Estimates

Ritonavirfor COVID19 (disease)

This trial is testing a medication to see if it can help treat people with COVID-19 who are immunocompromised and may benefit from a longer treatment duration.

Premium Medical Research Corp (+22 Sites)Pfizer CT.gov Call CenterPfizer

Image of GSK Investigational Site in Orlando, United States.

Phase-Based Progress Estimates

Cabotegravir OLIfor HIV Infections

This trial is testing two ways of delivering a medication to people who may be exposed to HIV, to see if either method is more effective or feasible.

GSK Investigational Site (+16 Sites)GSK Clinical TrialsViiV Healthcare

Image of SWOG in Portland, United States.

Phase-Based Progress Estimates

Cetuximabfor Cancer of Colon

This trial is testing whether adding nivolumab to the usual treatment of encorafenib and cetuximab works better at shrinking tumors in patients with colorectal cancer that has spread or cannot be removed by surgery.

SWOG (+99 Sites)Van K Morris

Image of Clinical Trial Site in Tampa, United States.

Phase-Based Progress Estimates

ALXN2050for Myasthenia Gravis, Generalized

This trial will test the efficacy and safety of ALXN2050 in people with gMG.

Clinical Trial Site (+20 Sites)Alexion Pharmaceuticals

Image of Neurocrine Clinical Site in Oklahoma City, United States.

Phase-Based Progress Estimates

NBI-1065846for Anhedonia

This trial is testing a new drug to see if it helps people with depression who are also taking an antidepressant.

Neurocrine Clinical Site (+15 Sites)Clinical Development LeadNeurocrine Biosciences

Image of Children's Hospital of Orange County in Orange, United States.

Phase-Based Progress Estimates

CD33*CD3 BsAbfor Leukemia, Myeloid, Acute

This trial is testing a new antibody drug to treat relapsed or refractory acute myeloid leukemia in pediatric patients.

Children's Hospital of Orange County (+12 Sites)Jessica Pollard, MDY-mAbs Therapeutics

Image of Johns Hopkins Medical Center in Baltimore, United States.

Phase-Based Progress Estimates

Enfortumab Vedotinfor Urinary Bladder Cancer

FDA Approved Drug

This trial will test a drug, given through a catheter, for side effects and efficacy in treating non-muscle invasive bladder cancer.

FDA Approved Drug

Johns Hopkins Medical Center (+7 Sites)Sujata Narayanan, MDSeagen Inc.

Image of Local Institution in Pensacola, United States.

Phase-Based Progress Estimates

Nivolumab + Relatlimab Fixed Dose Combinationfor Melanoma

FDA Approved Drug

This trial will compare nivolumab + relatlimab to nivolumab alone to see if the combo is more effective in treating melanoma.

FDA Approved Drug

Local Institution (+22 Sites)Bristol-Myers SquibbBristol-Myers Squibb

Image of University of Maryland in Baltimore, United States.

Phase-Based Progress Estimates

TCD601for Kidney

This trial will test how well a new drug works in combination with bone marrow cells from a donor to help prevent organ rejection in people who have recently received a kidney transplant.

University of Maryland (+5 Sites)Nick Hryciw, MAITB-Med LLC

Image of Start South Texas Accelerated Research Therapeutic in San Antonio, United States.

Phase-Based Progress Estimates

PY159/Pembrolizumab Combination Dose Expansion Cohortsfor Breast Cancer

FDA Approved Drug

This trial is testing a new drug to see if it is safe and effective in treating cancer that has spread or come back after other treatments.

FDA Approved Drug

Start South Texas Accelerated Research Therapeutic (+11 Sites)Lynnae JacksonGilead Sciences

Image of City of Hope Comprehensive Cancer Center in Duarte, United States.

Phase-Based Progress Estimates

Radiation Therapyfor Malignant neoplasm of prostate

FDA Approved Drug

This trial is testing two different intensities of hormone therapy and radiation therapy, comparing them to the current standard of care, in order to determine the best treatment plan for patients with high risk prostate cancer.

FDA Approved Drug

City of Hope Comprehensive Cancer Center (+99 Sites)Paul L Nguyen

Image of City of Hope Comprehensive Cancer Center in Duarte, United States.

Phase-Based Progress Estimates

Atezolizumabfor Endometrial Cancer

FDA Approved Drug

This trial is testing targeted cancer drugs plus atezolizumab, an immune checkpoint therapy, to see if it is effective and safe for patients with endometrial cancer that has come back or does not go away.

FDA Approved Drug

City of Hope Comprehensive Cancer Center (+15 Sites)Foundation Medicine

Image of Investigational Site Number 8400013 in Birmingham, United States.

Phase-Based Progress Estimates

Tolebrutinibfor Multiple Sclerosis

Waitlist Available

FDA Approved Drug

This trial is testing a new drug, SAR442168, to see if it is better than the existing drug, Aubagio, at reducing relapses in people with relapsing forms of MS. The trial will also look at other measures such as disability progression, MRI lesions, cognitive performance, and quality of life.

Waitlist Available

FDA Approved Drug

Investigational Site Number 8400013 (+15 Sites)Clinical Sciences & OperationsSanofi

Image of Local Institution in La Jolla, United States.

Phase-Based Progress Estimates

Nivolumabfor Non-Small Cell Lung Carcinoma (NSCLC)

Waitlist Available

FDA Approved Drug

This trial will compare two different treatments for locally advanced non-small cell lung cancer.

Waitlist Available

FDA Approved Drug

Local Institution (+25 Sites)Bristol-Myers SquibbBristol-Myers Squibb

Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Phase-Based Progress Estimates

Cisplatinfor Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8

FDA Approved Drug

This trial is studying a lower dose of radiation therapy with nivolumab for patients with HPV-positive oropharyngeal cancer that is early in growth.

FDA Approved Drug

University of Alabama at Birmingham Cancer Center (+99 Sites)Sue S Yom

Image of University of California, San Francisco - Investigational Drug Service (IDS) Pharmacy in San Francisco, United States.

Phase-Based Progress Estimates

PF-06838435/ Fidanacogene Elaparvovecfor Hemophilia B

Waitlist Available

This trial will test if a gene therapy drug is effective and safe in adult men with hemophilia B. The therapy is designed to replace Factor IX, which is missing or non-functioning in these patients. Those who participate will be given the therapy once and monitored for six years. The objective is to compare the annualized bleeding rate for those treated with gene therapy against the standard of care therapy.

Waitlist Available

University of California, San Francisco - Investigational Drug Service (IDS) Pharmacy (+15 Sites)Pfizer CT.gov Call CenterPfizer

Image of Elite Clinical Studies, LLC in Phoenix, United States.

Phase-Based Progress Estimates

Ozanimodfor Ileocolitis

FDA Approved Drug

This trial is testing a new drug to see if it is safe and effective for Crohn's Disease.

FDA Approved Drug

Elite Clinical Studies, LLC (+99 Sites)Kanthi Kollengode, MDCelgene

Image of Elite Clinical Studies, LLC in Phoenix, United States.

Phase-Based Progress Estimates

Ozanimodfor Ileocolitis

FDA Approved Drug

This trial is testing if ozanimod can help control Crohn's Disease.

FDA Approved Drug

Elite Clinical Studies, LLC (+99 Sites)Jerry Liu, MDCelgene

Image of HonorHealth Research Institute in Scottsdale, United States.

Phase-Based Progress Estimates

Ozanimodfor Ileocolitis

FDA Approved Drug

This trial is testing a new drug to see if it can help people with Crohn's Disease.

FDA Approved Drug

HonorHealth Research Institute (+62 Sites)Kanthi Kollengode, MDCelgene

Image of University Of Alabama At Birmingham in Birmingham, United States.

Phase-Based Progress Estimates

Nivolumabfor Tumor, Colorectal

FDA Approved Drug

This trial is looking at a new combination treatment for people with colon or rectal cancer that has spread and who have already been treated.

FDA Approved Drug

University Of Alabama At Birmingham (+32 Sites)Bristol-Myers SquibbBristol-Myers Squibb

Image of Anchorage Associates in Radiation Medicine in Anchorage, United States.

Phase-Based Progress Estimates

Pembrolizumabfor Adenocarcinoma of Lung

FDA Approved Drug

This trial looks at whether genetic testing can help select the best treatment for patients with early-stage non-small cell lung cancer.

FDA Approved Drug

Anchorage Associates in Radiation Medicine (+99 Sites)Geoffrey R Oxnard

Image of UCSF Mission Bay in San Francisco, United States.

Phase-Based Progress Estimates

Labyrinth VR Wirelessfor Mild Cognitive Impairment (MCI)

Therapeutic treatment is yet available for declining memory, which is an impairment affecting the quality of life for many older adults and patients with cognitive impairment. Cognitive training with an immersive video game promises to drive hippocampal-cortical plasticity and associated gains that can restore memory capability or provide therapeutic treatment for memory deficits.

UCSF Mission BayPeter E Wais, PhD

25 Clinical Trials San Francisco Near Me

Top Cities for Clinical Trials San Francisco

Image of San Francisco in California.

San Francisco

289Active Trials

University of California, San FranciscoTop Active Site

Image of New York in New York.

New York

175Active Trials

Memorial Sloan Kettering Cancer CenterTop Active Site